NCT06794164 Immediate Skin-To-Skin Care For Preterm Infants After Birth
| NCT ID | NCT06794164 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Effect of Skin to Skin Care in Preterm Neonates |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-02-03 |
| Primary Completion | 2027-02-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-02-03 with a primary completion date of 2027-02-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The standard procedure in our centre for preterm neonates is to enable skin-to-skin (SSC) contact within 24 hours after birth. As early SSC immediately after birth might provide numerous positive effects for mothers and their preterm neonates, the objective of this study is to evaluate the feasibility, the safety and the effect of skin-to-skin contact immediately after birth in preterm neonates born with gestational age between 26+0 and 32+0 weeks.
Eligibility Criteria
Inclusion Criteria: * Gestational age between 26+0 and 32+0 weeks * Written parental informed consent Exclusion Criteria: * No intention of full life support * Severe congenital malformation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06794164 clinical trial?
This trial is open to participants of all sexes, aged 0 Minutes or older, up to 30 Minutes, studying Effect of Skin to Skin Care in Preterm Neonates. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06794164 currently recruiting?
Yes, NCT06794164 is actively recruiting participants. Contact the research team at nariae.baik@medunigraz.at for enrollment information.
Where is the NCT06794164 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT06794164 clinical trial?
NCT06794164 is sponsored by Medical University of Graz. The trial plans to enroll 40 participants.